A clinical trial update dated July 28, 2026 lists the study status as completed for NCT07719933. The trial is titled "Intraoperative Continuous Terlipressin Infusion is Associated With Reduced Severe Postoperative Complications After Laparoscopic Hepatectomy: a Prospective Propensity Score-matched Cohort Study." No phase was specified for this trial in the available record.
The study is registered under identifier NCT07719933 and described as a prospective propensity score matched cohort study. It examines intraoperative continuous infusion of terlipressin in patients undergoing laparoscopic hepatectomy. The listed status confirms that the trial has concluded its data collection or study activities as of the update date.
This brief reports only the status change and trial title as recorded. No results, outcomes, or efficacy data are included in this update, and none should be inferred from the completed status alone. Lypressin, related to the vasopressin analog class referenced in this trial context, remains classified as unapproved for research use. Readers should consult the original registry entry for further procedural or methodological details as they become available.
For background on this compound and its research context, see the compound overview linked with this brief.</body_markdown>
<parameter name="sources">["https://clinicaltrials.gov/study/NCT07719933"]